Paper of the MonthEAN NewsFeatured Slider
Paper of the Month: Inebilizumab for the treatment of neuromyelitis optica (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
For December 2019, we have selected: Cree et al., Inebilizumab for the treatment of neuromyelitis optica (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial Lancet 2019 Epub ahead of print Sept 5.